UK BMT Pharmacists’ Group – Educational Meeting 5th March 2021

The UK BMT Pharmacists’ Group (a special-interest group affiliated to BOPA) is running an educational meeting via Zoom on the afternoon of Friday 5th March. The meeting will run from 1-5pm and the programme has been split into 4 x 1 hour slots to make it easy to dip in and out! Although the meeting will have a transplant-focus, the agenda has been made deliberately broad, and all pharmacists with an interest in haematology are very welcome to attend for some or all of the sessions. There is no registration fee and no need to pre-register.

 

The meeting agenda and all the details you need to log in can be found here: https://www.bopa.org.uk/bmtmeeting/

 

If you have any enquiries about the meeting please contact Nick Duncan at [email protected]

 

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article